Subtypes and Genetics: IPEX vs Adult-Onset AIE
At a Glance
Autoimmune enteropathy that starts in infancy is more likely to reflect an inherited immune problem such as IPEX, while adult-onset disease is usually linked to broader or unexplained autoimmunity. Genetic testing is especially important when symptoms begin early or affect several organs.
Autoimmune enteropathy (AIE) is not a single disease, but rather a pattern of immune-mediated damage that can have very different origins depending on when it begins. Doctors generally divide AIE into two main categories: pediatric-onset (usually occurring in infancy) and adult-onset. Understanding which type of AIE you or your child has is critical because it dictates whether the cause is likely a specific genetic mutation or a broader autoimmune tendency [1][2]. However, the pediatric-versus-adult framing is not categorical—monogenic immune dysregulation can present later in life, and adult AIE is not exclusively isolated to those in their 40s or 50s.
Pediatric-Onset and “Syndromic” AIE
When AIE appears in babies—often within the first six months of life—it is frequently syndromic, meaning the intestinal damage is just one part of a larger genetic condition [1]. In these cases, the immune system lacks the regulatory function needed to prevent it from attacking the body’s own organs [3].
The most well-known genetic form is IPEX syndrome, which stands for Immunodysregulation Polyendocrinopathy Enteropathy X-linked [4]. It is caused by a mutation in the FOXP3 gene, which is responsible for creating regulatory T-cells (the cells that keep the immune system in check) [5]. Because it is X-linked, it primarily affects boys [3].
In addition to severe diarrhea, children with IPEX or “IPEX-like” disorders often experience:
- Endocrinopathy: Early-onset autoimmune diseases of the hormone system, most commonly Type 1 Diabetes or thyroid disease [4].
- Dermatitis: Severe, persistent eczema or other skin rashes [4].
- Hematologic issues: Low blood counts (anemia or low platelets) caused by the immune system attacking blood cells [4].
IPEX-Like Disorders (CTLA4 and STAT3)
Not all infant-onset AIE is syndromic or caused by the FOXP3 gene. Researchers have identified “IPEX-like” conditions caused by mutations in other distinct inborn errors, such as CTLA4 and STAT3 [6][7].
- CTLA4 deficiency: This can cause a mix of intestinal attack and a weakened immune system that leads to frequent respiratory infections [2][8].
- STAT3 gain-of-function: This mutation causes the immune system to be overactive from birth, leading to early-onset autoimmunity across multiple organs [9][7].
Adult-Onset AIE: A Different Profile
Adult-onset AIE (typically diagnosed later in life) is rarely caused by a single genetic mutation like IPEX [10]. Instead, it is usually “idiopathic” (meaning the exact cause is unknown) or part of a broader tendency toward autoimmunity [11].
In adults, AIE is often linked to other autoimmune conditions, including:
- Autoimmune thyroiditis [12]
- Type 1 Diabetes [13]
- Pernicious anemia (an inability to absorb vitamin B12) [14]
- Myasthenia gravis or other neurological autoimmune issues [15]
Unlike the pediatric form, adult-onset AIE is more likely to be an “isolated” problem focusing mainly on the gut, though nearly half of adult patients in some cohorts will have at least one other autoimmune diagnosis [10].
The Importance of Genetic Testing
Because treatments can vary wildly based on the underlying cause, genetic testing has become a standard part of the AIE workup for younger patients, those with extraintestinal autoimmunity, or those with a suggestive family history [16].
- Genetic Counseling: Identifying a mutation allows other family members to be tested and helps parents understand the risks for future children. Genetic counseling should be a core part of this discussion to navigate variant uncertainty [16][17].
- Targeted Therapy: If a specific mutation like STAT3 is found, expert centers may consider experimental or indication-specific targeted drugs called JAK inhibitors [7].
- Definitive Treatment: For confirmed IPEX, a hematopoietic stem cell transplant (HSCT) is a potentially curative option. This is a highly specialized, high-risk decision based on exact variant and severity, not an automatic consequence of a FOXP3 result [18].
Whether the AIE is caused by a single gene or a complex autoimmune background, the goal remains the same: calming the immune attack and restoring the body’s ability to absorb the nutrients it needs to thrive.
Common questions in this guide
How is childhood autoimmune enteropathy different from adult-onset AIE?
What is IPEX syndrome, and which gene causes it?
When should a child with autoimmune enteropathy have genetic testing?
Can autoimmune enteropathy be caused by genes other than FOXP3?
How could a genetic result change treatment for AIE?
Does adult-onset autoimmune enteropathy rule out a genetic disorder?
If a gene change is found, should other family members be tested?
Get notified when new evidence is published on Primary autoimmune enteropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
A Review of Autoimmune Enteropathy and Its Associated Syndromes.
Chen CB, Tahboub F, Plesec T, et al.
Digestive diseases and sciences 2020; (65(11)):3079-3090 doi:10.1007/s10620-020-06540-8.
PMID: 32833153 - 2
A case of autoimmune enteropathy with CTLA4 haploinsufficiency.
Miyazaki H, Hoshi N, Kohashi M, et al.
Intestinal research 2022; (20(1)):144-149 doi:10.5217/ir.2020.00041.
PMID: 33476510 - 3
Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.
Louie RJ, Tan QK, Gilner JB, et al.
American journal of medical genetics. Part A 2017; (173(5)):1219-1225 doi:10.1002/ajmg.a.38144.
PMID: 28317311 - 4
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review.
Park JH, Lee KH, Jeon B, et al.
Autoimmunity reviews 2020; (19(6)):102526 doi:10.1016/j.autrev.2020.102526.
PMID: 32234571 - 5
Underlying IPEX syndrome in a patient with idiopathic juvenile arthritis and vitiligo.
Mendonça LO, Dos Reis Chuster AP, Dorna MB, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):105 doi:10.1186/s13223-022-00740-9.
PMID: 36503523 - 6
Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management.
Baxter SK, Walsh T, Casadei S, et al.
The Journal of allergy and clinical immunology 2022; (149(1)):327-339 doi:10.1016/j.jaci.2021.04.005.
PMID: 33864888 - 7
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
Leiding JW, Vogel TP, Santarlas VGJ, et al.
The Journal of allergy and clinical immunology 2023; (151(4)):1081-1095 doi:10.1016/j.jaci.2022.09.002.
PMID: 36228738 - 8
Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome.
Jamee M, Zaki-Dizaji M, Lo B, et al.
The journal of allergy and clinical immunology. In practice 2020; (8(8)):2747-2760.e7 doi:10.1016/j.jaip.2020.04.070.
PMID: 32428713 - 9
Intractable diarrhea in an infant-autoimmune enteropathy: A case report.
Tetarbe S, Shah K, Shah I
JPGN reports 2024; (5(1)):70-73 doi:10.1002/jpr3.12038.
PMID: 38545278 - 10
Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.
van Wanrooij RLJ, Neefjes-Borst EA, Bontkes HJ, et al.
Clinical and translational gastroenterology 2021; (12(8)):e00387 doi:10.14309/ctg.0000000000000387.
PMID: 34333499 - 11
Advances and challenges in diagnosing and managing adult autoimmune enteropathy.
Christodoulidis G, Agko SE, Kouliou MN, et al.
World journal of gastroenterology 2025; (31(2)):99118 doi:10.3748/wjg.v31.i2.99118.
PMID: 39811507 - 12
Autoimmune Encephalitis Misdiagnosis in Adults.
Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, et al.
JAMA neurology 2023; (80(1)):30-39 doi:10.1001/jamaneurol.2022.4251.
PMID: 36441519 - 13
A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
Sapana T, Li W, Tian F, et al.
Frontiers in immunology 2023; (14()):1274672 doi:10.3389/fimmu.2023.1274672.
PMID: 38077387 - 14
A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1.
Oftedal BE, Berger AH, Bruserud Ø, et al.
The Journal of clinical investigation 2023; (133(21)).
PMID: 37909333 - 15
Recurrent Autoimmune Encephalitis in a Patient With Autoimmune Polyendocrine Syndrome Type 1.
Stemple JT, Abulebda K, Ryan GF, et al.
Case reports in critical care 2026; (2026()):6086023 doi:10.1155/crcc/6086023.
PMID: 42157958 - 16
[New mutation in FOXP3 gene identified in an infant with chronic diarrhea as manifestation of autoinmune enteropathy - IPEX syndrome].
Plata García C, Martín-Marín L, Soler-Ramírez A, et al.
Revista chilena de pediatria 2020; (91(4)):584-590 doi:10.32641/rchped.v91i4.1467.
PMID: 33399737 - 17
Whole exome sequencing identified a novel splice donor site variant in interleukin 2 receptor alpha chain.
Waheed N, Naseer M, Haider N, et al.
Immunogenetics 2023; (75(2)):71-79 doi:10.1007/s00251-022-01278-1.
PMID: 36195682 - 18
Cyclophosphamide post-haploidentical stem cell transplantation experience in an infant with IPEX syndrome
Medina D, Ariza-Insignares C, Restrepo A, et al.
Biomedica : revista del Instituto Nacional de Salud 2025; (45(4)):521-527 doi:10.7705/biomedica.7755.
PMID: 41060163
This page is for informational purposes only and does not constitute medical advice. A gastroenterologist, immunologist, and genetic counselor can help interpret autoimmune enteropathy testing and discuss treatment options for you or your child.